ARTLVSMRNA• 6 Months (Normalized)
ARTL vs MRNA (Artelo Biosciences Inc. vs Moderna Inc.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-92.37%
Artelo Biosciences Inc.
Normalized Baseline0.00%
MRNA Performance $182.11
+%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-92.37 pts
MRNA outperforming by 92.37 percentage points
ARTLMRNA
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(121 dates)
| Date | ARTL Price | ARTL Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -92.37% | $- | - | |
| Sep 24, 2026 | $5.17 | -91.31% | $- | - | |
| Sep 23, 2026 | $7.31 | -87.71% | $182.11 | +273.41% | -361.12% |
| Sep 22, 2026 | $4.15 | -93.02% | $182.56 | +274.33% | -367.35% |
| Sep 21, 2026 | $4.10 | -93.11% | $172.94 | +254.60% | -347.71% |
| Sep 18, 2026 | $3.94 | -93.38% | $154.04 | +215.85% | -309.23% |
| Sep 17, 2026 | $3.97 | -93.33% | $158.07 | +224.11% | -317.44% |
| Sep 16, 2026 | $3.75 | -93.70% | $145.62 | +198.59% | -292.29% |
| Sep 15, 2026 | $5.34 | -91.02% | $143.77 | +194.79% | -285.81% |
| Sep 14, 2026 | $4.87 | -91.81% | $146.69 | +200.78% | -292.59% |
| Sep 11, 2026 | $5.43 | -90.87% | $143.97 | +195.20% | -286.07% |
| Sep 10, 2026 | $5.63 | -90.54% | $136.62 | +180.13% | -270.67% |
| Sep 09, 2026 | $5.98 | -89.95% | $135.61 | +178.06% | -268.01% |
| Sep 08, 2026 | $6.19 | -89.59% | $140.33 | +187.74% | -277.33% |
| Sep 04, 2026 | $6.04 | -89.85% | $145.55 | +198.44% | -288.29% |
Page 1 of 9